Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Dual Inhibition of Bruton's Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin's B Cell Malignancies.

Alfaro J, Pérez de Arce F, Belmar S, Fuentealba G, Avila P, Ureta G, Flores C, Acuña C, Delgado L, Gaete D, Pujala B, Barde A, Nayak AK, Upendra TVR, Patel D, Chauhan S, Sharma VK, Kanno S, Almirez RG, Hung DT, Chakravarty S, Rai R, Bernales S, Quinn KP, Pham SM, McCullagh E.

J Pharmacol Exp Ther. 2017 May;361(2):312-321. doi: 10.1124/jpet.116.238022. Epub 2017 Mar 15.

PMID:
28298527
2.

Purinergic Signaling as a Regulator of Th17 Cell Plasticity.

Fernández D, Flores-Santibáñez F, Neira J, Osorio-Barrios F, Tejón G, Nuñez S, Hidalgo Y, Fuenzalida MJ, Meza D, Ureta G, Lladser A, Pacheco R, Acuña-Castillo C, Guixé V, Quintana FJ, Bono MR, Rosemblatt M, Sauma D.

PLoS One. 2016 Jun 20;11(6):e0157889. doi: 10.1371/journal.pone.0157889. eCollection 2016.

3.

Generation of dendritic cells with regulatory properties.

Ureta G, Osorio F, Morales J, Rosemblatt M, Bono MR, Fierro JA.

Transplant Proc. 2007 Apr;39(3):633-7.

PMID:
17445563

Supplemental Content

Support Center